AIM Processing, an MCM Capital Partners Portfolio Company, Acquires Retlaw Industries
MCM Capital Partners (“MCM”), a Cleveland-based lower middle market private equity firm, today announced that its portfolio company AIM Processing (“AIM”) has acquired Retlaw Industries, Inc. (“Retlaw”) of Hartland, Wisconsin. This is AIM’s second add-on acquisition since MCM invested in the company in 2023, following Technical Molded Products in 2024.
Retlaw is a precision thermoplastic injection molder serving automation, food processing, industrial, outdoor power equipment and consumer customers. It specializes in high-precision, mission-critical components and offers integrated capabilities across design and engineering, in-house tooling and machining, and injection molding. Like AIM, Retlaw pairs automation with process engineering to run a highly efficient operation.
The acquisition broadens AIM’s press tonnage and in-house tooling capabilities, and it adds engineering depth, customers and a Midwest manufacturing footprint to AIM’s Colorado base. Together, the companies serve medical device, industrial, automation, food processing, government, water treatment, veterinary, laboratory and consumer markets.
“This is the second add-on for AIM, and it reflects both MCM’s support of AIM’s accelerated growth strategy and the upgraded executive team’s ability to take on a larger acquisition,” said Greg Ott, Senior Operating Partner at MCM Capital Partners and Chairman of AIM Processing. “The added customer and market diversity, expanded manufacturing and support capabilities, and additional geographic reach will be key to extending AIM’s growth trajectory and strengthening its market position.”
AIM is a portfolio company of MCM Capital Partners IV, L.P. Calfee, Halter & Griswold LLP served as legal counsel to MCM and AIM. KeyBank provided senior financing, and Oxer Capital provided mezzanine financing. TKO Miller served as exclusive investment banking advisor to Retlaw.
About AIM Processing
AIM Processing, based in Longmont, Colorado, is a custom injection molder specializing in small, highly engineered thermoplastic components for medical device, industrial, government, water treatment, veterinary and laboratory applications.
About MCM Capital Partners
For three decades, MCM has partnered with lower middle market businesses to support and accelerate growth, creating opportunities for business owners and their employees. We drive growth by applying a unique and powerful approach, going far beyond a “deal” mindset to inject extensive market and technology insights, along with proven best practices in operations, finance, and business development.
For inquiries about this transaction or MCM’s acquisition criteria, contact Chris Hren at [email protected]
